Interestingly, aside from the 3 ́UTR variant in GLRA2, none of the de novo variants in the Epi4k participants with MACF1 CH variants are in genes associated with neurological disease or predicted with confidence to have a negative impact on gene function. Here, GLRA2 is linked to nervous system disorder.